Header Logo

Connection

NEAL KLEIMAN to Thrombosis

Back to Details
This is a "connection" page, showing publications NEAL KLEIMAN has written about Thrombosis.
NEAL KLEIMAN
Connection Strength
3.365
Thrombosis
  1. Meta-Analysis Investigating the Role of Optical Coherence Tomography Versus Intravascular Ultrasound in Low-Risk Percutaneous Coronary Intervention. Am J Cardiol. 2022 02 01; 164:136-138.
    View in: PubMed
    Score: 0.512
  2. Direct Oral Anticoagulants Versus Vitamin K Antagonists in the Treatment of Left Ventricular Thrombi. Am J Cardiovasc Drugs. 2022 May; 22(3):231-238.
    View in: PubMed
    Score: 0.510
  3. Reticulated Platelets: Changing Focus from Basics to Outcomes. Thromb Haemost. 2018 Sep; 118(9):1517-1527.
    View in: PubMed
    Score: 0.408
  4. What Happens in the Cath Lab Stays in the Cath Lab, or Does It?: Intraprocedural Thrombotic Events in Patients With Acute Coronary Syndromes. JACC Cardiovasc Interv. 2016 Feb 22; 9(4):338-340.
    View in: PubMed
    Score: 0.342
  5. Expanding the Roster: Developing New Inhibitors of Intravascular Thrombosis. J Am Coll Cardiol. 2015 Jun 09; 65(22):2416-9.
    View in: PubMed
    Score: 0.327
  6. Searching for the ceiling: new reflections on the disposition and metabolism of clopidogrel. JACC Cardiovasc Interv. 2008 Dec; 1(6):628-30.
    View in: PubMed
    Score: 0.208
  7. Platelet reactivity in patients with subacute stent thrombosis compared with non-stent-related acute myocardial infarction. Am Heart J. 2007 Jan; 153(1):41.e1-6.
    View in: PubMed
    Score: 0.182
  8. Anti-thrombotic effect of bivalirudin compared with eptifibatide and unfractionated heparin in diabetic patients: an ex vivo human study. Thromb Haemost. 2006 Mar; 95(3):441-6.
    View in: PubMed
    Score: 0.172
  9. Intravascular imaging guided versus coronary angiography guided percutaneous coronary intervention: systematic review and meta-analysis. BMJ. 2023 11 16; 383:e077848.
    View in: PubMed
    Score: 0.147
  10. Long-term Outcomes of Transcatheter Aortic Valve Replacement With the Lotus Valve vs CoreValve/EvolutR: A Secondary Analysis of the REPRISE III Randomized Clinical Trial. JAMA Netw Open. 2022 10 03; 5(10):e2238792.
    View in: PubMed
    Score: 0.136
  11. Heparin monotherapy or bivalirudin during percutaneous coronary intervention in patients with non-ST-segment-elevation acute coronary syndromes or stable ischemic heart disease: results from the Evaluation of Drug-Eluting Stents and Ischemic Events registry. Circ Cardiovasc Interv. 2014 Jun; 7(3):365-73.
    View in: PubMed
    Score: 0.076
  12. Are we there yet? deciding when it is safe (and wise) to stop clopidogrel after stent implantation. J Interv Cardiol. 2014 Apr; 27(2):127-30.
    View in: PubMed
    Score: 0.075
  13. Evaluation of a new heparin agent in percutaneous coronary intervention: results of the phase 2 evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) Trial. Circulation. 2010 Apr 20; 121(15):1713-21.
    View in: PubMed
    Score: 0.057
  14. Platelets: developmental biology, physiology, and translatable platforms for preclinical investigation and drug development. Platelets. 2008 Jun; 19(4):239-51.
    View in: PubMed
    Score: 0.050
  15. Effect of P-selectin on phosphatidylserine exposure and surface-dependent thrombin generation on monocytes. Arterioscler Thromb Vasc Biol. 2005 May; 25(5):1065-70.
    View in: PubMed
    Score: 0.040
  16. Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry steering committee. J Thromb Thrombolysis. 2005 Feb; 19(1):11-9.
    View in: PubMed
    Score: 0.040
  17. In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry. Catheter Cardiovasc Interv. 2012 Dec 01; 80(7):1127-36.
    View in: PubMed
    Score: 0.017
  18. Effect of clopidogrel pretreatment on ischemic complications of percutaneous coronary intervention among bivalirudin-treated patients (from the EVENT registry). Am J Cardiol. 2011 Jun 15; 107(12):1751-6.
    View in: PubMed
    Score: 0.016
  19. Incidence and clinical outcome of minor surgery in the year after drug-eluting stent implantation: results from the Evaluation of Drug-Eluting Stents and Ischemic Events Registry. Am Heart J. 2011 Feb; 161(2):360-6.
    View in: PubMed
    Score: 0.015
  20. In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus- or paclitaxel-eluting stents: results from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry. JACC Cardiovasc Interv. 2009 Aug; 2(8):767-75.
    View in: PubMed
    Score: 0.014
  21. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA. 2007 May 09; 297(18):2001-9.
    View in: PubMed
    Score: 0.012
  22. Bivalirudin, thrombin and platelets: clinical implications and future directions. J Invasive Cardiol. 2003 Aug; Suppl:2-15.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.